Skip to Content
Merck
CN
  • Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma.

Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma.

Clinical and Experimental Allergy (2014)
Shen C, Hupin C, Froidure A, et al.